Definitions of growth failure Growth failure may be defined in various ways: (1) by a static measurement ofheight below the third centile; (2) by evidence of significant growth faltering as assessed over a period of time by centile chart analysis (that is, a shift from higher to lower centiles of height attained); (3) by showing a reduction in height velocity, which is the most accurate measurement of growth. Measurement of height velocity requires accurate measurement of height over a number of months (a minimum of three months). It may be defined as: (1) height velocity of less than the third centile by centile chart analysis4; (2) height velocity < -2.0 SDS (standard deviation score). 2 For research comparisons, standard deviation scores or Z scores are useful for defining changes in height percentile or in height velocity,5 but for routine clinical management centile chart analysis is both practical and adequate.
Prevalence of growth failure A survey of 96 children attending the paediatric inflammatory bowel disease clinic showed that 23% had heights below the third centile6 but 36% had height velocity below the third centile. 4 The American experience is similar.5 This is chiefly a problem of the adolescent and preadolescent years. The height of most younger children with Crohn's disease is normal.
Long term outcome of growth failure There are three published studies of children with chronic inflammatory bowel disease from prepuberty or early puberty through puberty until cessation of growth.2 5 7 While most patients achieved a final height between the fifth and the 97th centile the distribution was skewed towards the lower centiles, and in some children with Crohn's disease a significant reduction of final height was found. A single observation of 60 adults with so called juvenile onset of chronic inflammatory bowel disease showed that only three had impaired adult growth stature.8 However, 18 female patients had experienced menarche before the diagnosis of chronic inflammatory bowel disease. No pubertal staging of male patients was reported. The impact of disease on growth would be expected to be less in those patients whose disease preceded their peak growth velocity. As it is known that growth velocity is reduced in children with prepubertal onset of inflammatory bowel disease,2 it is difficult to compare outcome in such clinical series when populations are not at similar risk. 9 Clearly advances in modern treatment of chronic inflammatory bowel disease, both medical and surgical, are likely to have a beneficial outcome upon final height.9 10 Pubertal delay and growth failure Striking pubertal delay may occur in patients in whom a remission has never been successfully induced or in whom relapses have been frequent. 4 In the absence of a remission of disease activity the age of onset of puberty may be delayed indefinitely.
When the age of onset of puberty was taken as breast stage 2 (B2) in girls and testicular volume of 4 ml (IV4) in boys, a significant delay in onset ofpuberty was found in adolescents with chronic inflammatory bowel disease (fig 1) .
Precise pubertal staging (1-5) using the Tanner classification is important, and involves accurate measurement of testicular volume in boys using an orchidometer. Height increase during puberty may be impaired in these children. 4 There is a paradoxical effect in relation to delayed puberty. It urinary growth hormone secretion was found in patients on steroids. It is well known that steroids may blunt the growth hormone response. Although thyroid function is typically normal in children with Crohn's disease, there may be a reduced conversion of T4 to T3 leading to reduced T3 levels.26 These return promptly to normal on induction of remission.
In boys when there is extreme delay of puberty, that is, testicular volume below 10 ml, monthly intramuscular injections for 3-6 months of testosterone enanthate 125 mg may be helpful, especially when there is clinical remission of disease (Savage MO, personal communication). However, all medical treatment (enteral nutrition and drug therapy) may fail due to either (1) inability to induce or sustain an adequate disease remission, or (2) dependency on a dose of steroids which itself may impair growth, even when steroid sparing treatment with azathioprine has been used. Surgery may then offer a dramatic opportunity to produce a long standing remission and so restore growth, with the possibility of allowing catch up growth and a normal pubertal growth spurt when correctly timed'0 27 (table 1; fig 2) .
Thus surgery for growth retardation is indicated when there is failure of other treatment to induce an adequate remission. This surgical option is only possible when the disease is not too extensive and it is feasible to resect bowel27 (table 2) Surgical treatment performed up to the early stages of puberty may be dramatically helpful but if delayed until after puberty is well established, the opportuniy for growth restoration may be very limited or it may not be possible to achieve it at all (table 2) .
Whatever strategy is used to produce a remission, its completeness and duration through puberty is a key factor in influencing growth potential.'0 Months from surgery Figure 2 Height velocity before and after surgery. 
